These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 35923590)
21. A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems. Palmer JA; Mor V; Volandes AE; McCreedy E; Loomer L; Carter P; Dvorchak F; Mitchell SL Trials; 2018 Aug; 19(1):453. PubMed ID: 30134976 [TBL] [Abstract][Full Text] [Related]
22. Pragmatism in Pediatric Neurosurgery: More Than a Pipe Dream? A Systematic Literature Review and Analysis. Kik CC; Spoor JKH World Neurosurg; 2022 May; 161():418-423. PubMed ID: 35505562 [TBL] [Abstract][Full Text] [Related]
23. Pragmatic vs. explanatory: an adaptation of the PRECIS tool helps to judge the applicability of systematic reviews for daily practice. Koppenaal T; Linmans J; Knottnerus JA; Spigt M J Clin Epidemiol; 2011 Oct; 64(10):1095-101. PubMed ID: 21474282 [TBL] [Abstract][Full Text] [Related]
24. The need for more pragmatic trials in glaucoma research. Pacovska MF; de Amorim-Cabral CLD; Teixeira EGDRM; Kasahara N Eur J Ophthalmol; 2024 Apr; ():11206721241247428. PubMed ID: 38602016 [TBL] [Abstract][Full Text] [Related]
25. Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments. Saesen R; Depreytere K; Krupianskaya K; Langeweg J; Verheecke J; Lacombe D; Huys I BMC Med Res Methodol; 2023 Jun; 23(1):148. PubMed ID: 37355603 [TBL] [Abstract][Full Text] [Related]
26. How pragmatic is it? Lessons learned using PRECIS and RE-AIM for determining pragmatic characteristics of research. Gaglio B; Phillips SM; Heurtin-Roberts S; Sanchez MA; Glasgow RE Implement Sci; 2014 Aug; 9():96. PubMed ID: 25163664 [TBL] [Abstract][Full Text] [Related]
27. Integrating pragmatic and implementation science randomized clinical trial approaches: a PRagmatic Explanatory Continuum Indicator Summary-2 (PRECIS-2) analysis. Zatzick D; Palinkas L; Chambers DA; Whiteside L; Moloney K; Engstrom A; Prater L; Russo J; Wang J; Abu K; Iles-Shih M; Bulger E Trials; 2023 Apr; 24(1):288. PubMed ID: 37085877 [TBL] [Abstract][Full Text] [Related]
28. Making clinical trials more relevant: improving and validating the PRECIS tool for matching trial design decisions to trial purpose. Loudon K; Zwarenstein M; Sullivan F; Donnan P; Treweek S Trials; 2013 Apr; 14():115. PubMed ID: 23782862 [TBL] [Abstract][Full Text] [Related]
29. Facing the Realities of Pragmatic Design Choices in Environmental Health Studies: Experiences from the Household Air Pollution Intervention Network Trial. Checkley W; Hossen S; Rosa G; Thompson LM; McCracken JP; Diaz-Artiga A; Balakrishnan K; Simkovich SM; Underhill LJ; Nicolaou L; Hartinger SM; Davila-Roman VG; Kirby MA; Clasen TF; Rosenthal J; Peel JL; On Behalf Of Household Air Pollution Intervention Network Hapin Investigators Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409475 [TBL] [Abstract][Full Text] [Related]
30. How pragmatic are the randomised trials used in recommendations for control of glycosylated haemoglobin levels in type 2 diabetic patients in general practice: an application of the PRECIS II tool. Ettori-Ajasse I; Tatin E; Forbes G; Eldridge S; Dibao-Dina C Trials; 2020 Mar; 21(1):281. PubMed ID: 32188470 [TBL] [Abstract][Full Text] [Related]
31. The PRECIS-2 tool has good interrater reliability and modest discriminant validity. Loudon K; Zwarenstein M; Sullivan FM; Donnan PT; Gágyor I; Hobbelen HJSM; Althabe F; Krishnan JA; Treweek S J Clin Epidemiol; 2017 Aug; 88():113-121. PubMed ID: 28603007 [TBL] [Abstract][Full Text] [Related]
32. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
33. Using PRECIS-2 in Chinese herbal medicine randomized controlled trials for irritable bowel syndrome: A methodological exploration based on literature. Luo M; Wang Y; Huang J; Li Y; Li W; Li H; Liu Z; Liu M; Tao Y; Liu J; Fei Y Integr Med Res; 2024 Sep; 13(3):101053. PubMed ID: 39219983 [TBL] [Abstract][Full Text] [Related]
34. Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains. Lipman PD; Loudon K; Dluzak L; Moloney R; Messner D; Stoney CM Trials; 2017 Nov; 18(1):532. PubMed ID: 29126437 [TBL] [Abstract][Full Text] [Related]
35. An application of PRECIS-2 to evaluate trial design in a pilot cluster randomised controlled trial of a community-based smoking cessation intervention for women living in disadvantaged areas of Ireland. Darker C; Loudon K; O'Connell N; Castello S; Burke E; Vance J; Reynolds C; Buggy A; Dougall N; Williams P; Dobbie F; Bauld L; Hayes CB Pilot Feasibility Stud; 2022 Jan; 8(1):19. PubMed ID: 35078530 [TBL] [Abstract][Full Text] [Related]
36. Use of pragmatic randomized trials in multiple sclerosis: A systematic overview. Hirt J; Janiaud P; Düblin P; Nicoletti GJ; Dembowska K; Nguyen TVT; Woelfle T; Axfors C; Yaldizli Ö; Granziera C; Kuhle J; Kappos L; Hemkens LG Mult Scler; 2024 Apr; 30(4-5):463-478. PubMed ID: 38253528 [TBL] [Abstract][Full Text] [Related]
37. Using the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) model in clinical research: Application to refine a practice-based research network (PBRN) study. Elder WG; Munk N J Am Board Fam Med; 2014; 27(6):846-54. PubMed ID: 25381083 [TBL] [Abstract][Full Text] [Related]
38. Is immediate imaging important in managing low back pain? Andersen JC J Athl Train; 2011; 46(1):99-102. PubMed ID: 21214357 [TBL] [Abstract][Full Text] [Related]
39. Use of PRECIS ratings in the National Institutes of Health (NIH) Health Care Systems Research Collaboratory. Johnson KE; Neta G; Dember LM; Coronado GD; Suls J; Chambers DA; Rundell S; Smith DH; Liu B; Taplin S; Stoney CM; Farrell MM; Glasgow RE Trials; 2016 Jan; 17():32. PubMed ID: 26772801 [TBL] [Abstract][Full Text] [Related]
40. Comments, suggestions, and criticisms of the Pragmatic Explanatory Continuum Indicator Summary-2 design tool: a citation analysis. Willis A; Shiely F; Treweek S; Taljaard M; Loudon K; Howie A; Zwarenstein M J Clin Epidemiol; 2024 Dec; 176():111534. PubMed ID: 39284517 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]